ID   ZNF41_HUMAN             Reviewed;         821 AA.
AC   P51814; A8K1V6; B4DH01; Q96LE8; Q9UMC4; Q9UMV5; Q9UMV6; Q9UMV7; Q9UMV8;
AC   Q9UMV9; Q9UMW0; Q9UMW1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   28-JUN-2023, entry version 216.
DE   RecName: Full=Zinc finger protein 41;
GN   Name=ZNF41;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=10449920; DOI=10.1159/000015315;
RA   Rosati M., Franze A., Matarazzo M.R., Grimaldi G.;
RT   "Coding region intron/exon organization, alternative splicing and X-
RT   chromosome inactivation of the KRAB/FPB-domain-containing human zinc finger
RT   gene ZNF41.";
RL   Cytogenet. Cell Genet. 85:291-296(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 6).
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 280-821.
RX   PubMed=2037297; DOI=10.1016/0888-7543(91)90367-n;
RA   Franze A., Archidiacono N., Rocchi M., Marino M., Grimaldi G.;
RT   "Isolation and expression analysis of a human zinc finger gene (ZNF41)
RT   located on the short arm of the X chromosome.";
RL   Genomics 9:728-736(1991).
RN   [7]
RP   ALTERNATIVE SPLICING, TISSUE SPECIFICITY, CHROMOSOMAL TRANSLOCATION,
RP   VARIANTS LEU-153; ARG-167 AND GLU-357, AND POSSIBLE ASSOCIATION OF VARIANT
RP   LEU-153 WITH X-LINKED INTELLECTUAL DISABILITY.
RX   PubMed=14628291; DOI=10.1086/380309;
RA   Shoichet S.A., Hoffmann K., Menzel C., Trautmann U., Moser B.,
RA   Hoeltzenbein M., Echenne B., Partington M., Van Bokhoven H., Moraine C.,
RA   Fryns J.-P., Chelly J., Rott H.-D., Ropers H.-H., Kalscheuer V.M.;
RT   "Mutations in the ZNF41 gene are associated with cognitive deficits:
RT   identification of a new candidate for X-linked mental retardation.";
RL   Am. J. Hum. Genet. 73:1341-1354(2003).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-120 AND LYS-647, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [9]
RP   LACK OF ASSOCIATION OF VARIANT LEU-153 WITH X-LINKED INTELLECTUAL
RP   DISABILITY.
RX   PubMed=23871722; DOI=10.1016/j.ajhg.2013.06.013;
RA   Piton A., Redin C., Mandel J.L.;
RT   "XLID-causing mutations and associated genes challenged in light of data
RT   from large-scale human exome sequencing.";
RL   Am. J. Hum. Genet. 93:368-383(2013).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       P51814; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-2681830, EBI-10175124;
CC       P51814; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-2681830, EBI-10172290;
CC       P51814-6; Q8IZU0: FAM9B; NbExp=6; IntAct=EBI-12700258, EBI-10175124;
CC       P51814-6; P55081: MFAP1; NbExp=3; IntAct=EBI-12700258, EBI-1048159;
CC       P51814-6; Q6ZUT1: NKAPD1; NbExp=3; IntAct=EBI-12700258, EBI-3920396;
CC       P51814-6; Q15287: RNPS1; NbExp=3; IntAct=EBI-12700258, EBI-395959;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P51814-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51814-2; Sequence=VSP_006883;
CC       Name=3;
CC         IsoId=P51814-3; Sequence=VSP_006884;
CC       Name=4;
CC         IsoId=P51814-4; Sequence=VSP_006887;
CC       Name=5;
CC         IsoId=P51814-5; Sequence=VSP_006886;
CC       Name=6;
CC         IsoId=P51814-6; Sequence=VSP_006885;
CC       Name=7;
CC         IsoId=P51814-7; Sequence=VSP_006883, VSP_006888;
CC       Name=8;
CC         IsoId=P51814-8; Sequence=VSP_006885, VSP_006888;
CC   -!- TISSUE SPECIFICITY: Expressed in the heart, brain, placenta, lung,
CC       liver, skeletal muscle, kidney and pancreas.
CC       {ECO:0000269|PubMed:14628291}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ZNF41 has been found
CC       in a patient with severe intellectual disability. Translocation
CC       t(X;7)(p11.3;q11.21). {ECO:0000269|PubMed:14628291}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- CAUTION: Although ZNF41 has been reported to be involved in X-linked
CC       intellectual disability (PubMed:14628291), its pathological role is
CC       questionable (PubMed:23871722). {ECO:0000305|PubMed:14628291,
CC       ECO:0000305|PubMed:23871722}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X60155; CAB51740.1; -; mRNA.
DR   EMBL; AJ010017; CAB53035.1; -; mRNA.
DR   EMBL; AJ010018; CAB53036.1; -; mRNA.
DR   EMBL; AJ010019; CAB53037.1; -; mRNA.
DR   EMBL; AJ010020; CAB53038.1; -; mRNA.
DR   EMBL; AJ010021; CAB53039.1; -; mRNA.
DR   EMBL; AJ010022; CAB53040.1; -; mRNA.
DR   EMBL; AJ010023; CAB53041.1; -; mRNA.
DR   EMBL; AK290021; BAF82710.1; -; mRNA.
DR   EMBL; AK294858; BAG57962.1; -; mRNA.
DR   EMBL; AL590223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471164; EAW59303.1; -; Genomic_DNA.
DR   EMBL; BC015023; AAH15023.1; -; mRNA.
DR   EMBL; M92443; AAA61312.1; -; Genomic_DNA.
DR   CCDS; CCDS14279.1; -. [P51814-6]
DR   PIR; A54661; A54661.
DR   RefSeq; NP_001311068.1; NM_001324139.1. [P51814-4]
DR   RefSeq; NP_001311069.1; NM_001324140.1. [P51814-6]
DR   RefSeq; NP_001311070.1; NM_001324141.1. [P51814-4]
DR   RefSeq; NP_001311071.1; NM_001324142.1. [P51814-2]
DR   RefSeq; NP_001311072.1; NM_001324143.1. [P51814-4]
DR   RefSeq; NP_001311073.1; NM_001324144.1. [P51814-6]
DR   RefSeq; NP_001311074.1; NM_001324145.1. [P51814-4]
DR   RefSeq; NP_001311076.1; NM_001324147.1. [P51814-6]
DR   RefSeq; NP_001311077.1; NM_001324148.1. [P51814-2]
DR   RefSeq; NP_001311078.1; NM_001324149.1. [P51814-4]
DR   RefSeq; NP_001311079.1; NM_001324150.1. [P51814-6]
DR   RefSeq; NP_001311080.1; NM_001324151.1. [P51814-3]
DR   RefSeq; NP_001311081.1; NM_001324152.1. [P51814-4]
DR   RefSeq; NP_001311082.1; NM_001324153.1. [P51814-3]
DR   RefSeq; NP_001311083.1; NM_001324154.1. [P51814-5]
DR   RefSeq; NP_001311084.1; NM_001324155.1. [P51814-1]
DR   RefSeq; NP_001311085.1; NM_001324156.1. [P51814-7]
DR   RefSeq; NP_001311086.1; NM_001324157.1. [P51814-8]
DR   RefSeq; NP_009061.1; NM_007130.3. [P51814-6]
DR   RefSeq; NP_700359.1; NM_153380.3. [P51814-6]
DR   RefSeq; XP_006724613.1; XM_006724550.3. [P51814-5]
DR   RefSeq; XP_006724618.1; XM_006724555.3. [P51814-3]
DR   RefSeq; XP_016885299.1; XM_017029810.1. [P51814-5]
DR   RefSeq; XP_016885300.1; XM_017029811.1. [P51814-5]
DR   RefSeq; XP_016885301.1; XM_017029812.1. [P51814-5]
DR   RefSeq; XP_016885302.1; XM_017029813.1. [P51814-5]
DR   RefSeq; XP_016885303.1; XM_017029814.1. [P51814-5]
DR   RefSeq; XP_016885304.1; XM_017029815.1. [P51814-5]
DR   RefSeq; XP_016885305.1; XM_017029816.1. [P51814-3]
DR   RefSeq; XP_016885306.1; XM_017029817.1. [P51814-6]
DR   AlphaFoldDB; P51814; -.
DR   SMR; P51814; -.
DR   BioGRID; 113418; 8.
DR   IntAct; P51814; 9.
DR   MINT; P51814; -.
DR   iPTMnet; P51814; -.
DR   PhosphoSitePlus; P51814; -.
DR   BioMuta; ZNF41; -.
DR   DMDM; 20141930; -.
DR   EPD; P51814; -.
DR   jPOST; P51814; -.
DR   MassIVE; P51814; -.
DR   MaxQB; P51814; -.
DR   PeptideAtlas; P51814; -.
DR   ProteomicsDB; 56410; -. [P51814-1]
DR   ProteomicsDB; 56411; -. [P51814-2]
DR   ProteomicsDB; 56412; -. [P51814-3]
DR   ProteomicsDB; 56413; -. [P51814-4]
DR   ProteomicsDB; 56414; -. [P51814-5]
DR   ProteomicsDB; 56415; -. [P51814-6]
DR   ProteomicsDB; 56416; -. [P51814-7]
DR   ProteomicsDB; 56417; -. [P51814-8]
DR   ABCD; P51814; 1 sequenced antibody.
DR   Antibodypedia; 25429; 244 antibodies from 20 providers.
DR   DNASU; 7592; -.
DR   Ensembl; ENST00000313116.11; ENSP00000315173.7; ENSG00000147124.13. [P51814-6]
DR   Ensembl; ENST00000377065.8; ENSP00000366265.4; ENSG00000147124.13. [P51814-6]
DR   Ensembl; ENST00000684689.1; ENSP00000508254.1; ENSG00000147124.13. [P51814-6]
DR   GeneID; 7592; -.
DR   KEGG; hsa:7592; -.
DR   MANE-Select; ENST00000684689.1; ENSP00000508254.1; NM_001324144.2; NP_001311073.1. [P51814-6]
DR   UCSC; uc004dhx.5; human. [P51814-1]
DR   AGR; HGNC:13107; -.
DR   CTD; 7592; -.
DR   DisGeNET; 7592; -.
DR   GeneCards; ZNF41; -.
DR   HGNC; HGNC:13107; ZNF41.
DR   HPA; ENSG00000147124; Low tissue specificity.
DR   MalaCards; ZNF41; -.
DR   MIM; 314995; gene.
DR   neXtProt; NX_P51814; -.
DR   OpenTargets; ENSG00000147124; -.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA37682; -.
DR   VEuPathDB; HostDB:ENSG00000147124; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000163107; -.
DR   HOGENOM; CLU_002678_17_1_1; -.
DR   InParanoid; P51814; -.
DR   OMA; SIHQKSH; -.
DR   OrthoDB; 5253872at2759; -.
DR   PhylomeDB; P51814; -.
DR   TreeFam; TF350810; -.
DR   PathwayCommons; P51814; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   SignaLink; P51814; -.
DR   BioGRID-ORCS; 7592; 15 hits in 804 CRISPR screens.
DR   ChiTaRS; ZNF41; human.
DR   GeneWiki; ZNF41; -.
DR   GenomeRNAi; 7592; -.
DR   Pharos; P51814; Tbio.
DR   PRO; PR:P51814; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P51814; protein.
DR   Bgee; ENSG00000147124; Expressed in muscle of leg and 113 other tissues.
DR   ExpressionAtlas; P51814; baseline and differential.
DR   Genevisible; P51814; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 17.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24381; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24381:SF405; ZINC FINGER PROTEIN 819; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 17.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 17.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 10.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 17.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 18.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; DNA-binding;
KW   Isopeptide bond; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..821
FT                   /note="Zinc finger protein 41"
FT                   /id="PRO_0000047374"
FT   DOMAIN          69..140
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         313..335
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         341..364
FT                   /note="C2H2-type 2; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         369..391
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         397..419
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         425..447
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         453..475
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         481..503
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         509..531
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         537..559
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         565..587
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         593..615
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         621..643
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         649..671
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         677..699
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         705..727
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         733..755
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         761..783
FT                   /note="C2H2-type 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         789..811
FT                   /note="C2H2-type 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..55
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        21..39
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        647
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..128
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_006887"
FT   VAR_SEQ         1..60
FT                   /note="MAANGDSPPWSPALAAEGRGSSCEVRRERTPEARIHSVKRYPDLSPGPKGRS
FT                   SADHAALN -> MGTLPHGPRPWLQRDVAAHV (in isoform 7 and isoform
FT                   2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006883"
FT   VAR_SEQ         1..52
FT                   /note="MAANGDSPPWSPALAAEGRGSSCEVRRERTPEARIHSVKRYPDLSPGPKGRS
FT                   -> MGTLPHGPRPWLQRDVAAHV (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006884"
FT   VAR_SEQ         25..66
FT                   /note="Missing (in isoform 6 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_006885"
FT   VAR_SEQ         53..60
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006886"
FT   VAR_SEQ         141..176
FT                   /note="Missing (in isoform 7 and isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006888"
FT   VARIANT         153
FT                   /note="P -> L (rare variant found in patients with X-linked
FT                   intellectual disability; unknown pathological significance;
FT                   dbSNP:rs104894955)"
FT                   /evidence="ECO:0000269|PubMed:14628291"
FT                   /id="VAR_021785"
FT   VARIANT         167
FT                   /note="I -> R (in dbSNP:rs17147624)"
FT                   /evidence="ECO:0000269|PubMed:14628291"
FT                   /id="VAR_021786"
FT   VARIANT         357
FT                   /note="D -> E (in dbSNP:rs2498170)"
FT                   /evidence="ECO:0000269|PubMed:14628291"
FT                   /id="VAR_021787"
FT   CONFLICT        111
FT                   /note="Q -> R (in Ref. 1; CAB53039)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   821 AA;  93728 MW;  F44B7808C9A8AF13 CRC64;
     MAANGDSPPW SPALAAEGRG SSCEVRRERT PEARIHSVKR YPDLSPGPKG RSSADHAALN
     SIVSLQASVS FEDVTVDFSK EEWQHLDPAQ RRLYWDVTLE NYSHLLSVGY QIPKSEAAFK
     LEQGEGPWML EGEAPHQSCS GEAIGKMQQQ GIPGGIFFHC ERFDQPIGED SLCSILEELW
     QDNDQLEQRQ ENQNNLLSHV KVLIKERGYE HKNIEKIIHV TTKLVPSIKR LHNCDTILKH
     TLNSHNHNRN SATKNLGKIF GNGNNFPHSP SSTKNENAKT GANSCEHDHY EKHLSHKQAP
     THHQKIHPEE KLYVCTECVM GFTQKSHLFE HQRIHAGEKS RECDKSNKVF PQKPQVDVHP
     SVYTGEKPYL CTQCGKVFTL KSNLITHQKI HTGQKPYKCS ECGKAFFQRS DLFRHLRIHT
     GEKPYECSEC GKGFSQNSDL SIHQKTHTGE KHYECNECGK AFTRKSALRM HQRIHTGEKP
     YVCADCGKAF IQKSHFNTHQ RIHTGEKPYE CSDCGKSFTK KSQLHVHQRI HTGEKPYICT
     ECGKVFTHRT NLTTHQKTHT GEKPYMCAEC GKAFTDQSNL IKHQKTHTGE KPYKCNGCGK
     AFIWKSRLKI HQKSHIGERH YECKDCGKAF IQKSTLSVHQ RIHTGEKPYV CPECGKAFIQ
     KSHFIAHHRI HTGEKPYECS DCGKCFTKKS QLRVHQKIHT GEKPNICAEC GKAFTDRSNL
     ITHQKIHTRE KPYECGDCGK TFTWKSRLNI HQKSHTGERH YECSKCGKAF IQKATLSMHQ
     IIHTGKKPYA CTECQKAFTD RSNLIKHQKM HSGEKRYKAS D
//
